[Biojava-dev] BioJava 3 code usage examples

[Richard Holland]

I like the domain registration idea better. I'll find out what the
folks at open-bio think.

cheers,
Richard

2008/11/20  <mark.schreiber at novartis.com>:
>
> biojava-dev-bounces at lists.open-bio.org wrote on 11/21/2008 09:02:37 AM:
>
>> Hello. Thanks for spending the time looking into the code. It's a bit
>> like a virtual code review session for me... you've made some very
>> useful comments.
>>
>> > 1) It doesn't seem that you want to avoid name conflicts with the old
>> > version because you are continuing using the package name
>> > "org.biojava.*"
>> > instead of "org.biojava3.*"
>>
>> Yes, I agree, I think they should be changed to org.biojava3. I will
>> do this when I get 5 minutes spare. They should be in org.biojava3
>> because one of the stated goals was to be able to write a
>> biojava-biojava3 mapper module if someone needed that to happen, and
>> the use of org.biojava in the new code would preclude that.
>>
>
> I think it would be a very good idea to differentiate this from old code via
> the packages. Strictly speaking you are supposed to use a domain that you
> own. I don't know if biojava3.org is available or if open-bio wants to
> obtain it. It's not critical but it would prevent possible issues.
>
> Alternatives would be to use org.biojava.v3.*
>
> or you could use the open-bio domain as in org.open-bio.biojava3
>
> - Mark
>
> _________________________
>
> CONFIDENTIALITY NOTICE
>
> The information contained in this e-mail message is intended only for the
> exclusive use of the individual or entity named above and may contain
> information that is privileged, confidential or exempt from disclosure under
> applicable law. If the reader of this message is not the intended recipient,
> or the employee or agent responsible for delivery of the message to the
> intended recipient, you are hereby notified that any dissemination,
> distribution or copying of this communication is strictly prohibited. If you
> have received this communication in error, please notify the sender
> immediately by e-mail and delete the material from any computer.  Thank you.
>



-- 
Richard Holland, BSc MBCS
Finance Director, Eagle Genomics Ltd
M: +44 7500 438846 | E: holland at eaglegenomics.com
http://www.eaglegenomics.com/